it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.
.
.
.
.
scott cadger, head of underwriting and claims strategy at scottish widows, said the industry needed to do more to educate the public on the merits of protection insurance.
.
.